Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Sleep disorder
Clinical narrative: Rash spread to face, neck, chest, up to eyebrows intensifying with itching interrupting sleep; Interrupting sleep; Mild rash on chin and jaw; This is a spontaneous report from a contactable consumer (patient) reported in response to non-Health Care Professional letter sent in cross-reference case. A 47-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6198, Expiration date was not reported), via an unspecified route of administration, in left arm on 23Feb2021 at 14:30 (at the age of 47-year-old) as DOSE 2, SINGLE for COVID-19 immunization in public health department. Relevant medical history reported as none. Family medical history relevant was reported as none. Concomitant medication included metronidazole (FLAGYL) on 24Jan2021 with stop date as 31Jan2021 was prescribed due to bacterial vaginosis following hysterectomy, levocetirizine dihydrochloride (XYZAL) on 01Sep2020, still ongoing and melatonin on 01Jan2020, still ongoing are taken for an unspecified indication. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9264, Expiration date was not reported), via an unspecified route of administration, in right arm on 27Jan2021 at 16:30 (at the age of 47-year-old) as DOSE 1, SINGLE for COVID-19 immunization in public health department and experienced mild rash developed on chin within 48 hours. Within a week, the rash spread to neck, upper lip, nose, and eyebrows. By two weeks, the rash worsened and developed red bumps and blisters with intense itching and burning 24 hours a day and severe rash eyebrows down to chest itching interrupting sleep. On 25Feb2021, patient experienced mild rash on chin and jaw. On 28Feb2021, rash spread to face, neck, chest, up to eyebrows intensifying with itching interrupting sleep. These events resulted in visit to physician office. The patient was not hospitalized, and no emergency room visit due to the events. Patient reported that she was fine now. Vaccination administered at military facility was reported as no. The patient did not receive any other vaccines within four weeks prior to the vaccination. Relevant testes were reported as none. There were no predisposing factors and culture was not preformed. The primary infection site was reported as face, neck and chest. Both vaccinations are included as the same reaction with the exact same timing occurred with both. At time of first dose Flagyl was prescribed due to bacterial vaginosis following hysterectomy. Therapeutic measures were taken as a result of all events which included Allegra, Singulair, Doxepin all was started on 10Feb2021 and stopped on 19Mar2021 and Elidel. Three antihistamines were prescribed and helped with ability to sleep but redness and daytime itching continued for several weeks. The outcome of the event rash spread to neck, chest, up to eyebrows intensifying with itching interrupting sleep was reported as recovered on 15Mar2021, while the other event was recovered in 2021. No follow-up attempts are possible. No further information was expected.